https://www.selleckchem.com/products/ms-275.html
Among cerebral venous thrombosis (CVT) patients, those with venous infarction have more severe clinical presentations and worse outcomes. Identifying biomarkers associated with venous infarction in CVT may help understand the pathogenesis and provide potentially useful therapeutic markers. Fifty-two CVT patients were prospectively recruited and divided into three groups acute/subacute CVT with venous infarction (ASVI, n=3, without venous infarction (ASOVI, n=13), and chronic CVT (n=9). Blood brain barrier (BB permeability-related pro
Like
Comment
Share
